share_log

Mizuho Initiates Coverage On LifeMD With Neutral Rating, Announces Price Target of $7

Mizuho Initiates Coverage On LifeMD With Neutral Rating, Announces Price Target of $7

瑞穗开始对LifeMD进行中立评级,宣布目标价格为7美元
Benzinga ·  12/04 19:08  · 评级/大行评级

Mizuho analyst Steven Valiquette initiates coverage on LifeMD (NASDAQ:LFMD) with a Neutral rating and announces Price Target of $7.

瑞穗分析师史蒂芬·瓦利奎特启动对LifeMD(纳斯达克:LFMD)的覆盖,给予中立评级,并宣布目标价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发